The impact of obesity on 30-day complications in pediatric surgery

A T Train1, S B Cairo2, H A Meyers2

  • 1Department of Pediatric Surgery, Women and Children's Hospital of Buffalo, 219 Bryant Street, Buffalo, NY, 14222, USA. Ariannet@buffalo.edu.

Insights

Obesity increases wound complication risks in pediatric surgery but decreases other complications and morbidity. The impact of obesity on surgical outcomes is complex and depends on the procedure and specialty.

Area of Science:

  • Pediatric Surgery
  • Obesity Research
  • Surgical Outcomes

Background:

  • Obesity is a growing concern in pediatric populations.
  • Understanding its impact on surgical outcomes is crucial for patient care.

Purpose of the Study:

  • To investigate the effects of pediatric obesity on surgical outcomes across different surgical specialties.
  • To analyze the association between obesity and postoperative complications, including wound complications and overall morbidity.

Main Methods:

  • Retrospective cohort study utilizing the National Surgical Quality Improvement Program (NSQIP) Pediatric database (2012-2014).
  • Included patients aged 2-17 years undergoing surgery in six specialties.
  • Multivariate regression analysis was used to calculate odds ratios for postoperative complications.

Main Results:

  • Obesity was linked to a higher risk of wound complications (OR 1.24) but a lower risk of non-wound complications (OR 0.68) and morbidity (OR 0.79).
  • No significant association between obesity and complications was found in otolaryngology or plastic surgery.
  • Obese children experienced longer anesthesia and operative times in most pediatric surgical procedures.

Conclusions:

  • Pediatric obesity presents a complex relationship with surgical outcomes, increasing wound complication risk in certain specialties.
  • Obesity is associated with reduced non-wound complications and morbidity overall.
  • Procedure- and specialty-specific factors appear more influential on obesity's impact on surgical outcomes than previously thought.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
313
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
303
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
228
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
830
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
441